JW (Cayman) Therapeutics Co. Ltd (2126.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 937.38M |
| Enterprise Value | 696.77M |
| P/E Ratio | -2.87 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 3.35 |
| Price/Book Ratio | 2.11 |
| Enterprise/Revenue | 2.87 |
| Enterprise/EBITDA | -4.1 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.17 |
| Operating Margin | -0.95 |
AD
Management Effectiveness
| Return On Assets | -0.4 |
| Return On Equity | -0.66 |
Income Statement
| Revenue | 276.31M |
| Revenue/Share | 0.69 |
| Gross Profit | 118.91M |
| EBITDA | -159.83M |
| Net Income | -540.92M |
| Diluted EPS | -1.3 |
Balance Sheet
| Total Cash | 392.02M |
| Total Cash/Share | 0.94 |
| Total Debt | 254.85M |
| Total Debt/Equity | 0.56 |
| Current Ratio | 1.43 |
| Book Value Per Share | 1.09 |
Price History
| 52-Week Change | -23.51 |
| 52-Week High | 3.74 |
| 52-Week Low | 1.4 |
| Moving Average 50 Days | 2.44 |
| Moving Average 200 Days | 2.12 |
Statistics
| Average Volume | 1.51M |
| Shares Outstanding | 416.73M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
